Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
11/2009
11/24/2009CA2420962C Method for preparing crystal of 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid
11/24/2009CA2418794C Calcium receptor antagonists
11/24/2009CA2415383C New amidino derivatives and their use as thrombin inhibitors
11/24/2009CA2385882C Tyrosine derivatives
11/24/2009CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/19/2009WO2009139373A1 Amide compound
11/19/2009WO2009137916A1 Processes and intermediates for the preparation of oseltamivir and analogs thereof
11/19/2009WO2009115334A3 Process for the manufacture of memantine and intermediate product
11/19/2009US20090287020 Process for producing high-purity n-vinylcarboxamides
11/19/2009US20090286833 Substituted Cyclohexylmethyl Compounds
11/19/2009US20090286828 2-amino-1-phenylethylcarboxamide derivatives
11/19/2009US20090286765 Therapeutic Agents
11/19/2009US20090285888 Derivatives of dihydroxyphenylalanine
11/19/2009CA2724077A1 Amide compound
11/18/2009EP2118051A1 New compounds, methods for their preparation and use thereof
11/18/2009EP2018367B1 Novel microbiocides
11/18/2009CN101583287A N-substituted-p-menthane-3-carboxamide and uses thereof
11/18/2009CN101580477A Dehydroabietylamine derivatives and application thereof in bactericidal and antineoplastic medicaments
11/18/2009CN100560662C Cyclic bisamides useful in formulating inks for phase-change printing
11/18/2009CN100560561C Optically pure alpha-difluoromethylamine and method of highly stereo-selective preparation
11/17/2009US7619004 Method of using colchicine for prophylactic treatment of gout flares in a human gout patient so as to reduce the occurrence of colchicine toxicity when patient is receiving concomitant administration of clarithromycin; dosage adjustment
11/12/2009WO2009137082A1 4-isopropylcyclohexylcarbonyl amino acid derivatives
11/12/2009WO2009135860A1 Method for manufacturing aryl carboxamides
11/12/2009WO2009098458A3 Difluorobiphenylamide derivatives for the treatment of ocular hypertension
11/12/2009US20090281154 Ophthalmic Compositions for Treating Ocular Hypertension
11/12/2009US20090280230 Comestible compositions comprising high potency savory flavorants, and processes for producing them
11/12/2009CA2721695A1 Method for manufacturing aryl carboxamides
11/11/2009EP2114864A1 Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
11/11/2009EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009CN101578260A Insecticidal compounds
11/11/2009CN101578259A 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
11/11/2009CN101576539A Method for measuring impurity A in xylometazoline hydrochloride
11/11/2009CN100558697C Cycloalkyl inhibitors of potassium channel function
11/10/2009US7615664 E.g., 2 N-(2-Fluorophenyl)-5(S)-amino-4(S)-hydroxy-2(S)-isopropyl-7(S)-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide; renin inhibitors used for the treatment of hypertension, heart failure, glaucoma, myocardial infarction, kidney failure, restenoses or stroke
11/10/2009US7614879 Dental self-etching primer
11/10/2009CA2315262C Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
11/05/2009WO2009132979A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009WO2009132978A1 4-dimethylaminobutyric acid derivatives
11/05/2009WO2009132453A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009WO2009132452A1 Diaryl-cyclylalkyl derivatives as calcium channel blockers
11/05/2009US20090275758 Process for phenylacetic acid derivatives
11/05/2009US20090275714 New Ruthenium Complexes as Catalysts for Metathesis Reactions
11/05/2009CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009CA2722114A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009CA2722087A1 4-dimethylaminobutyric acid derivatives
11/04/2009EP1915335B1 Process for the preparation of cinacalcet base
11/04/2009EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
11/04/2009EP1216226B1 Process for phenylacetic acid derivatives
11/04/2009CN101570494A N-phenyl-dichloroacetamide and derivatives as well as preparation method and application thereof
11/03/2009US7612236 Method for producing optically active bisamidoalcohol compound
11/03/2009US7612225 Endothelin receptor antagonist, useful for treating various circulatory system diseases such as hypertension, ischemic disorders, cerebral circulatory disorders, renal disorders, circulatory insufficiency of various organs, asthma, stroke
11/03/2009US7612036 Such as methyl (2S,5S,8R/S)-8-acetamido-2-allyl-9-[6-allyl-9-tert-butoxycarbonyl-9H-carbazol-3-yl]-3,6-diaza-5-{3-[(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-guanidino]propyl}-4,7-dioxononanoate; for treatment of bacterial infections, such as those caused by vancomycin resistant microorganisms
11/03/2009CA2497074C Substituted spirocyclic ketoenols
11/03/2009CA2427579C Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions
10/2009
10/29/2009WO2009130735A1 Fatty acid derivatives for oral administration endowed with high palatability
10/29/2009WO2009129938A1 Substituted phenoxybenzamides
10/29/2009US20090270510 Glycine transport inhibitors
10/29/2009US20090270470 Compounds I
10/29/2009CA2721756A1 Fatty acid derivatives for oral administration endowed with high palatability
10/28/2009EP2112135A2 E2, E4,Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same
10/28/2009EP2111223A1 Amine derivative compounds for treating ophthalmic diseases and disorders
10/28/2009CN101565435A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
10/28/2009CN101565383A Method for synthesizing 3-amino-4-methacetin by catalytic hydrogenation
10/28/2009CN101565382A Method for synthesizing acetamide
10/28/2009CN101564681A Solid phase extraction column of chloromycetin molecularly imprinted polymer and preparation method thereof
10/28/2009CN100553631C Pharmaceutical uses of 4-fluoro-N-(1,2- hydrindenl-2-yl) benzamide
10/27/2009US7608737 N-(2-(7-(methoxy-d3)-naphthalen-1-yl)ethyl)acetamide-d3, a deuterated derivative of Agomelatine; side effect reduction; decreased metabolic liability; pharmakinetics; bioavailability;antidepressants; anxiolytic agents; bipolar disorders; dual melatoninergic agonist and serotoninergic antagonist
10/27/2009CA2536870C Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
10/27/2009CA2465534C Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/22/2009WO2009129267A2 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264414 Amide Derivatives and Pharmaceutical Use Thereof
10/22/2009CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009EP1166766B1 External preparation compositions
10/21/2009CN101560169A Preparation method of N-(trans-4-isopropylcyclohexyl-1-formyl)-D-phenylalanine
10/21/2009CN101560168A Preparation method of benorilate
10/21/2009CN101560132A Method for racemizing chiral amino acid or derivatives of chiral amino acid
10/21/2009CN100551903C Process for recovering dimethyl amide from waste water using ion liquid extracting process
10/20/2009US7605289 N-Benzyl-N-methyl-4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)benzamide; modulating activity of hydroxysteroid dehydrogenases (HSDs), 11 beta-hydroxysteroid dehydrogenases,(also; 17 beta-, 20 alpha-, and 3 alpha-); antidiabetic agents;, obesity, glaucoma, osteoporosis, cognitive disorders; immunotherapy
10/20/2009US7605288 2,5-(Aminocarbonylalkylene-(3,5-dihydroxy,6-halo-1,2-phenylene)-carbonyloxyalkylene)-)-p-quinone; chimera, mimetics of radicicol and geldanamycin; anticarcinogenic agents; antitumor agents; decreased toxicity; increased solubility and selectivity; enzyme inhibitors
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/15/2009WO2009125606A1 Pai-1 inhibitor
10/15/2009WO2009125565A1 Ruthenium compound and method for producing optically active aminoalcohol compound
10/15/2009WO2009125409A2 Fatty acid amides and uses thereof
10/15/2009WO2009093028A3 Polychromic substances and their use
10/15/2009WO2009066072A3 Inhibitors of 17beta-hydroxysteroid dehydrogenase
10/15/2009US20090259058 Process for the Preparation of Prostaglandin Analogues and Intermediates Thereof
10/15/2009US20090258884 Substituted amides
10/15/2009CA2720096A1 Pai-1 inhibitor
10/14/2009EP2108036A2 Process for the production of alkanolamide
10/14/2009EP1718582B1 Method for selective reduction of aromatic compounds
10/14/2009EP1390343B1 Novel retinoid derivatives and an anti-cancer pharmaceutical composition comprising said compounds
10/14/2009CN101555211A Chemical synthesis method of 2-acylamino-3-biphenyl propionic acid
10/14/2009CN101554409A Long pepper alkaloid and preparation method, preparation and application thereof
10/14/2009CN100548971C Process for the preparation of polyisocyanate
10/13/2009US7601876 Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
10/13/2009US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
10/13/2009US7601870 Substituted aniline derivatives
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 289